Earnings before interest, tax, depreciation, and amortisation (EBITDA) rose 74.7% to ₹2,341.7 crore, against ₹1,340.5 crore a year ago, exceeding the CNBC-TV18 estimate of ₹1,774.2…
After a subdued start, the market struggled to sustain early gains and remained under pressure throughout the day.
Finance Minister Nirmala Sitharaman said that the consumption horizon is “glaring” with demand “coming out like an arc” post the GST reforms on September 22.
Singtel is reportedly planning to sell a 0.8% stake in Bharti Airtel through a ₹10,300-crore block deal at a floor price of ₹2,030 per share.…
The board of directors has declared an interim dividend of ₹5.40 per equity share, representing 540% of the face value of Re.1 each, fully paid…
Revenue from operations grew 3.4% quarter-on-quarter to ₹1,328.9 crore, driven by growth in its BFSI and Lifesciences & Services verticals, even as the manufacturing segment…
The contract will be executed within 24 months and involves the design, supply, testing, and commissioning of traction substations, sectioning posts (SPs), and sub-sectioning posts…
Aarti Industries reports Q2 FY26 net profit of ₹106 crore.
Revenue from operations rose 1% year-on-year to ₹1,915 crore from ₹1,896 crore, driven by underlying volume growth of 3%, partially offset by pricing adjustments. Shares…
GSK’s entry into Oncology with the launch of specialised therapies Jemperli (Dostarlimab) and Zejula (Niraparib) was well-received by healthcare professionals. Shares of GlaxoSmithKline Pharmaceuticals Ltd…